Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies

El-Laithy, Hanan M.; Shoukry, Omar; Mahran, Laila

doi:10.1016/j.ejpb.2010.10.011

Cited by 184 publications

(102 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the HLB is not the only factor that affects EE. The phase transition temperature (T c ) is directly proportional to the length of hydrocarbon alkyl chains of surfactants (Mohammed et al, 2004;Guinedi et al, 2005;El-Laithy et al, 2011). Surfactants with a higher T c and longer alkyl chain show higher EE because they are more likely to form gels in an ordered form with less ''leaky'' niosomes (ElLaithy et al, 2011).…”

Section: Entrapment Efficiency and Vesicle Sizementioning

confidence: 99%

Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder

et al. 2015

View full text Add to dashboard Cite

Context: Overactive bladder (OAB) is a common problem and anticholinergic drugs are first-line therapy, but they have side effects. Objective: Development of oxybutynin chloride (OC) proniosomal gels and analyses of its efficacy for OAB treatment. Materials and methods: Phase separation coacervation was used to prepare proniosomal gels using various non-ionic surfactants, lipids, soy lecithin and isopropyl alcohol. Gels were characterized with regard to entrapment efficiency (EE), vesicle size, surface morphology (using environmental scanning electron microscopy [E-SEM]), stability, attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy, in vitro skin permeation, in vivo animal studies and histopathology. Results and discussion: EE was 87-92%, vesicle size was 0.38-5.0 mm, and morphology showed some loosened pores in proniosomes after hydration. ATR-FTIR spectroscopy showed no significant shifts in peaks corresponding to OC and excipients. Most formulations exhibited 450% permeation but the cholesterol-containing formulations P3 (Span 20:Span 60 [1:1]) and P4 [Tween 20:Tween 80 (1:1)] had the highest percent cumulative permeation. P3 and P4 also showed faster recovery of cholinergic effects on salivary glands than oral formulations. P3 and P4 had pronounced therapeutic effects in reduction of urinary frequency and demonstrated improvements in bladder morphology (highly regenerative surface of the transitional epithelium). Conclusion: These results suggest that OC could be incorporated into proniosomal gels for transdermal delivery in the treatment of OAB.

show abstract

Section: Entrapment Efficiency and Vesicle Sizementioning

confidence: 99%

Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder

et al. 2015

View full text Add to dashboard Cite

show abstract

“…The skin permeation of BCT from the optimised formulation (F 3 S 60 ) and control was performed using skins obtained from the Wistar Albino rats using vertical Franz diffusion cell. [36] BCT dispersed in carbopol 934 gel was used as a control. After 48 h of the study period, only 33.034% of BCT of the control permeated thorough the rat skin while it was 86.191% in case of proniosomal formulation ( Figure 4).…”

Section: Skin Permeation Studiesmentioning

confidence: 99%

Proniosomal gel-mediated transdermal delivery of bromocriptine:in vitroandex vivoevaluation

Lather¹,

Sharma²,

Pandita³

2016

Journal of Experimental Nanoscience

View full text Add to dashboard Cite

Vesicular systems endow large opportunities for the transdermal delivery of therapeutics. The present study was designed to investigate the potential of a novel class of vesicular system 'proniosome' as a carrier for transdermal delivery of bromocriptine (BCT). Proniosome formulations were prepared by the coacervationphase separation method and the influence of factors like surfactant type and its amount, lipid concentration, cholesterol amount and drug content were studied. Span 60 was the most appropriate surfactant, and yielded vesicle size and percentage encapsulation efficiency of 1.3 mm and 98.9%, respectively. The developed system was characterised w.r.t. morphology, transition temperature, drug release, skin permeation and skin irritancy. Proniosomes exhibited a sustained release pattern of BCT in vitro. Skin permeation study revealed high penetration of proniosomes with sustained release of BCT through rat skin. The optimised proniosomal formulation showed enhanced transdermal flux of 16.15 mg/cm 2 /h as compared to 3.67 mg/cm 2 /h for drug dispersion. The developed formulations were observed as non-irritant to the rat skin and were found as quite stable at 4 and 25 C for 90 days w.r.t. vesicle size and drug content. The dried proniosomal formulation could act as a promising alternative to niosomes and preferably for transdermal delivery of BCT.

show abstract

“…The supernatant was taken and diluted with appropriate medium and PZ concentration in the resulting solution was assayed by UV-spectrophotometer at 270 nm. The percentage of drug entrapment was calculated by the following equation (El-Laithy et al, 2011).…”

Section: Entrapment Efficiencymentioning

confidence: 99%

“…Moreover, it has been reported in several studies, that compared to conventional dosage forms, lipid vesicular formulations exhibited an enhanced drug bioavailability (Manconi et al, 2006;Mura et al, 2007;Shumilov & Touitou, 2010;Imam et al, 2013;Vitorino et al, 2013). Particular efforts have been aimed at using niosomes as effective dermal and transdermal drug delivery systems (Aboelwafa et al, 2010;El-Laithy et al, 2011;Muzzalupo et al, 2011;Junyaprasert et al, 2012;Imam et al, 2013). Pioglitazone (PZ) is a thiazolidinedione derivative with structural formula 5-[4-[2-(5-Ethyl-2-pyridinyl) ethoxy] benzyl] thiazolidine-2,4-dione (Reginato & Lazar, 1999;Waugh et al, 2006).…”

Section: Introductionmentioning

confidence: 99%

QbD-based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes

et al. 2014

View full text Add to dashboard Cite

In order to develop transdermal drug delivery system that facilitates the skin permeation of Pioglitazone (PZ) encapsulated in carbopol-based transgel system (proniosomes/niosome). The developed formulations were optimized using quality by design (QbD) approach and particle size, percentage entrapment and transdermal flux were determined. It was found to be more efficient delivery carriers with high encapsulation and enhanced flux value demonstrated that the permeation of PZ through skin was significantly increased with developed formulation. The transdermal enhancement from proniosome was 3.16 times higher than that of PZ from control formulation (ethanol buffer formulation, 3:7), which was further confirmed by confocal laser scanning microscopy. In vivo pharmacokinetic study of carbopol transgel showed a significant increase in bioavailability (2.26 times) compared with tablet formulation. It also showed better antidiabetic activity in comparison to marketed tablet, so our results suggest that carbopol-based transgel are an efficient carrier for delivery of pioglitazone through skin.

show abstract

Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies

Cited by 184 publications

References 56 publications

Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder

Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder

Proniosomal gel-mediated transdermal delivery of bromocriptine:in vitroandex vivoevaluation

QbD-based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes

Contact Info

Product

Resources

About